Arvelle Therapeutics International GmbH
a company of Angelini Pharma Group
Zählerweg 6
6301 – Zug (Switzerland)

Angelini Pharma Headquarters
Viale Amelia, 70
00181 – Rome (Italy)

Product Safety

For health-related issues, we encourage you to contact your doctor or health care provider.

For the notification to Arvelle/Angelini of undesirable side effects, product complaints and medical information enquiries, please use a contact detail reported below:

tel: +41 0800 005 625

Follow us on social media

Connect with us and stay up to date with our research and development.